Archon Capital Management’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,070
| Closed | -$1M | – | 42 |
|
|
2020
Q1 | $1M | Hold |
1,070
| – | – | 0.37% | 23 |
|
|
2019
Q4 | $1.48M | Buy |
1,070
+408
| +62% | +$564K | 0.25% | 24 |
|
|
2019
Q3 | $1.56M | Buy |
662
+38
| +6% | +$89.3K | 0.37% | 24 |
|
|
2019
Q2 | $2.29M | Buy |
624
+132
| +27% | +$485K | 0.42% | 22 |
|
|
2019
Q1 | $2.93M | Buy |
492
+326
| +196% | +$1.94M | 0.8% | 20 |
|
|
2018
Q4 | $410K | Buy |
+166
| New | +$410K | 0.17% | 26 |
|